Is acriflavine an efficient co-drug in chemotherapy?-Reference-Cited by-同舟云学术

Is acriflavine an efficient co-drug in chemotherapy?

Published:2023 Issue:31 Volume:13 Page:21421-21431
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Piorecka Kinga¹^ORCID,Kurjata Jan¹^ORCID,Gostynski Bartłomiej¹^ORCID,Kazmierski Slawomir¹^ORCID,Stanczyk Wlodzimierz A.¹^ORCID,Marcinkowska Monika²^ORCID,Janaszewska Anna²^ORCID,Klajnert-Maculewicz Barbara²^ORCID

Affiliation:

1. Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, Lodz, 90-363, Poland

2. Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska St., 90-236 Lodz, Poland

Abstract

In this work, we describe the acriflavine–doxorubicin complex as a multitasking platform in the fight against cancer. The most important goal of these studies was to assess the biological activity of these complexes against cervical cancer cells.

Funder

Polska Akademia Nauk

Wydział Biologii i Ochrony Środowiska, Uniwersytet Łódzki

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/RA/D3RA02608F

Reference51 articles.

1. Thermodynamic Dissection of the Intercalation Binding Process of Doxorubicin to dsDNA with Implications of Ionic and Solvent Effects

2. Synthetic routes to nanomaterials containing anthracyclines: noncovalent systems

3. Synthetic routes to nanoconjugates of anthracyclines

4. Intercalation of antitumor drug doxorubicin and its analogue by DNA duplex: Structural features and biological implications

5. Molecular mechanism and binding free energy of doxorubicin intercalation in DNA